glp-1 receptor agonist with dpp-4 inhibitor combination not recommended Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Table 2 from DPP- 4

Unlike temporary weight-loss methods, GLP-1 therapy supports a gradual transformation of your metabolic set point. Clinical data shows that patients often continue to see health improvements for 12 to 18 months before reaching a stable maintenance level

The net result is lower blood pressure despite a harder-working heart

Recent advances in the relationship between obesity, inflammation, and insulin resistance

GLP-1-related hair loss typically peaks 24 months after the triggering event (usually rapid weight loss) and begins to resolve over the following 36 months

2018;26:931 Li Y, Tian H, Zeng H, Zhang Y, Yin T, He H, et al